SOURCE: StockCall


April 13, 2011 09:58 ET

Research on Rite Aid Corp. and CVS Caremark Corporation -- New Generics Impacting Drug Stores' Revenues

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Apr 13, 2011) - offers investors comprehensive research on the Drug Stores industry and has completed analytical research on Rite Aid Corp. (NYSE: RAD) and CVS Caremark Corporation (NYSE: CVS). Register with us today at to have free access to these researches.

While much of the talk about patent cliffs has circled around brand name producers, expiring patents for brand name drugs and their subsequent replacement by cheaper generic alternatives is also negatively impacting companies in the Drug Stores Industry. With generics working against them, companies in the industry have been taking a number of approaches to try and offset new generic losses. Visit to see how companies in this industry have grown over the past years and how they are expected to perform in the future. is an online platform where investors doing their due-diligence on the Drug Stores industry can have easy and free access to our analyst research and opinions on Rite Aid Corp. and CVS Caremark Corporation; investors and shareholders of these companies can simply register for a complimentary membership at

Companies such as Rite Aid Corp. and CVS Caremark Corp. have both reported the negative effects of new generics on their revenues. However, many in the industry are reporting increases in same store sales, as well as increased front end sales. Investors can register for free to access the research reports on Rite Aid Corp. and CVS Caremark Corporation at or

In an attempt to bolster their market share, some in the industry are relying on promotional activities. Rite Aid has been working hard to get customers enrolled in their rewards program. The company now boasts more than 36 million members. CVS Caremark has been offering their "To Your Health" free screening program, designed to provide preventative health screenings, in a number of cities. Register now at to have free access to our reports on the Drug Stores industry.

About is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information